Citigroup
STJ

Citigroup’s St Jude Medical STJ Stock Holding History

Citigroup’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,594,746
Closed -$368M – 7540
2016
Q4 		$368M Buy
4,594,746
+190,755
+4% +$15.1M 0.33% 32
2016
Q3 		$351M Sell
4,403,991
-140,041
-3% -$11.3M 0.33% 34
2016
Q2 		$354M Buy
4,544,032
+4,502,427
+10,822% +$321M 0.36% 33
2016
Q1 		$2.29M Buy
41,605
+32,364
+350% +$1.76M ﹤0.01% 2338
2015
Q4 		$571K Sell
9,241
-20,279
-69% -$1.28M ﹤0.01% 3715
2015
Q3 		$1.86M Sell
29,520
-10,973
-27% -$783K ﹤0.01% 2513
2015
Q2 		$2.96M Sell
40,493
-5,110
-11% -$369K ﹤0.01% 2201
2015
Q1 		$2.98M Buy
45,603
+26,762
+142% +$1.78M ﹤0.01% 2152
2014
Q4 		$1.23M Sell
18,841
-59,082
-76% -$3.81M ﹤0.01% 2934
2014
Q3 		$4.69M Buy
77,923
+7,589
+11% +$496K ﹤0.01% 1889
2014
Q2 		$4.87M Sell
70,334
-92,291
-57% -$5.98M ﹤0.01% 1819
2014
Q1 		$10.6M Buy
162,625
+31,294
+24% +$2.04M 0.01% 1108
2013
Q4 		$8.14M Sell
131,331
-74,305
-36% -$4.3M 0.01% 1406
2013
Q3 		$11M Buy
205,636
+60,838
+42% +$3.13M 0.01% 1095
2013
Q2 		$6.61M Buy
+144,798
New +$6.27M 0.01% 1394

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Citigroup's STJ Position: Q1 2017 in Review

Citigroup sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,594,746 shares — an estimated $368M sold.

Citigroup first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $368M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Citigroup reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Citigroup sold 4,594,746 St Jude Medical shares in Q1 2017, an estimated $368M.
  • Citigroup first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Citigroup's St Jude Medical position peaked at $368M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.